NM_014141.6:c.3633G>A

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_014141.6(CNTNAP2):​c.3633G>A​(p.Glu1211Glu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00877 in 1,614,160 control chromosomes in the GnomAD database, including 93 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0064 ( 12 hom., cov: 33)
Exomes 𝑓: 0.0090 ( 81 hom. )

Consequence

CNTNAP2
NM_014141.6 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: 0.543

Publications

3 publications found
Variant links:
Genes affected
CNTNAP2 (HGNC:13830): (contactin associated protein 2) This gene encodes a member of the neurexin family which functions in the vertebrate nervous system as cell adhesion molecules and receptors. This protein, like other neurexin proteins, contains epidermal growth factor repeats and laminin G domains. In addition, it includes an F5/8 type C domain, discoidin/neuropilin- and fibrinogen-like domains, thrombospondin N-terminal-like domains and a putative PDZ binding site. This protein is localized at the juxtaparanodes of myelinated axons, and mediates interactions between neurons and glia during nervous system development and is also involved in localization of potassium channels within differentiating axons. This gene encompasses almost 1.5% of chromosome 7 and is one of the largest genes in the human genome. It is directly bound and regulated by forkhead box protein P2, a transcription factor related to speech and language development. This gene has been implicated in multiple neurodevelopmental disorders, including Gilles de la Tourette syndrome, schizophrenia, epilepsy, autism, ADHD and intellectual disability. [provided by RefSeq, Jul 2017]
CNTNAP2 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AR, AD Classification: DEFINITIVE, NO_KNOWN Submitted by: ClinGen
  • cortical dysplasia-focal epilepsy syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Illumina, Labcorp Genetics (formerly Invitae), Orphanet, G2P, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.53).
BP6
Variant 7-148383806-G-A is Benign according to our data. Variant chr7-148383806-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 95570.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.543 with no splicing effect.
BS1
Variant frequency is greater than expected in population sas. GnomAdExome4 allele frequency = 0.00901 (13176/1461858) while in subpopulation SAS AF = 0.0168 (1451/86254). AF 95% confidence interval is 0.0161. There are 81 homozygotes in GnomAdExome4. There are 6778 alleles in the male GnomAdExome4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 12 AR,AD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_014141.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CNTNAP2
NM_014141.6
MANE Select
c.3633G>Ap.Glu1211Glu
synonymous
Exon 22 of 24NP_054860.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CNTNAP2
ENST00000361727.8
TSL:1 MANE Select
c.3633G>Ap.Glu1211Glu
synonymous
Exon 22 of 24ENSP00000354778.3
CNTNAP2
ENST00000463592.3
TSL:1
c.-37G>A
5_prime_UTR
Exon 2 of 4ENSP00000486292.1
CNTNAP2
ENST00000628930.2
TSL:2
c.810G>Ap.Glu270Glu
synonymous
Exon 7 of 9ENSP00000487516.1

Frequencies

GnomAD3 genomes
AF:
0.00640
AC:
974
AN:
152184
Hom.:
12
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00167
Gnomad AMI
AF:
0.0340
Gnomad AMR
AF:
0.00255
Gnomad ASJ
AF:
0.00144
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.0161
Gnomad FIN
AF:
0.00650
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.00974
Gnomad OTH
AF:
0.00766
GnomAD2 exomes
AF:
0.00791
AC:
1987
AN:
251270
AF XY:
0.00896
show subpopulations
Gnomad AFR exome
AF:
0.00173
Gnomad AMR exome
AF:
0.00214
Gnomad ASJ exome
AF:
0.000893
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.00753
Gnomad NFE exome
AF:
0.00994
Gnomad OTH exome
AF:
0.00701
GnomAD4 exome
AF:
0.00901
AC:
13176
AN:
1461858
Hom.:
81
Cov.:
33
AF XY:
0.00932
AC XY:
6778
AN XY:
727228
show subpopulations
African (AFR)
AF:
0.00119
AC:
40
AN:
33480
American (AMR)
AF:
0.00226
AC:
101
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00142
AC:
37
AN:
26134
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.0168
AC:
1451
AN:
86254
European-Finnish (FIN)
AF:
0.00856
AC:
457
AN:
53394
Middle Eastern (MID)
AF:
0.0101
AC:
58
AN:
5768
European-Non Finnish (NFE)
AF:
0.00950
AC:
10562
AN:
1112008
Other (OTH)
AF:
0.00778
AC:
470
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
848
1696
2543
3391
4239
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
380
760
1140
1520
1900
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00640
AC:
975
AN:
152302
Hom.:
12
Cov.:
33
AF XY:
0.00620
AC XY:
462
AN XY:
74486
show subpopulations
African (AFR)
AF:
0.00166
AC:
69
AN:
41562
American (AMR)
AF:
0.00255
AC:
39
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.00144
AC:
5
AN:
3468
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5180
South Asian (SAS)
AF:
0.0161
AC:
78
AN:
4832
European-Finnish (FIN)
AF:
0.00650
AC:
69
AN:
10616
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.00976
AC:
664
AN:
68030
Other (OTH)
AF:
0.00758
AC:
16
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
47
93
140
186
233
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00844
Hom.:
3
Bravo
AF:
0.00551
Asia WGS
AF:
0.00549
AC:
19
AN:
3478
EpiCase
AF:
0.0104
EpiControl
AF:
0.00871

ClinVar

ClinVar submissions as Germline
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
6
not specified (6)
-
-
2
Cortical dysplasia-focal epilepsy syndrome (2)
-
-
2
not provided (2)
-
-
1
Inborn genetic diseases (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.53
CADD
Benign
5.9
DANN
Benign
0.57
PhyloP100
0.54
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs138477292; hg19: chr7-148080898; COSMIC: COSV105926238; API